Ravenquest Biomed has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Ravenquest Biomed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of September 2024 and ending today, the 1st of December 2024. Click here to learn more.
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. The company has 123.62 M outstanding shares. More on Ravenquest Biomed
Ravenquest Biomed cannot be verified against its exchange. Apparently, Ravenquest Biomed is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ravenquest Biomed [RVVQF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 48.21 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ravenquest Biomed's market, we take the total number of its shares issued and multiply it by Ravenquest Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ravenquest Biomed classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 123.62 M outstanding shares.
Ravenquest Biomed has accumulated about 749.13 K in cash with (11.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Ravenquest Biomed Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Ravenquest Biomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Insider Screener Now
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Other Information on Investing in Ravenquest Pink Sheet
Ravenquest Biomed financial ratios help investors to determine whether Ravenquest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ravenquest with respect to the benefits of owning Ravenquest Biomed security.